However, the anorexic nature of GDF15 and its association with cancer cachexia and chemotherapy-induced anorexia have hampered its therapeutic potential in the treatment of obesity. This evidence concerns the gene GDF15 and obesity due to melanocortin 4 receptor deficiency.